Defining and Implementing Quality in Clinical Investigations from Design to Completion

Venue: Washington Marriott Hotel

Location: Washington, District Of Columbia, United States

Event Date/Time: May 10, 2007 End Date/Time: May 11, 2007
Report as Spam


Join us for the first-of-its-kind workshop on building in and implementing quality in modern clinical investigations from the inception of the research through its completion.

As clinical investigations become more complex and global, FDA must continue to evolve and modernize the oversight and monitoring of research. In June 2006, FDA announced the BIMO Initiative, which specifically addresses concerns surrounding the protection of human subjects and the integrity of data in clinical trials ( topics/NEWS/2006/NEW01396.html).

FDA continues to seek input from clinical researchers and all other revel ant parties on the challenges of and potential solutions for the establishment of an integrated approach to data quality, data integrity, and human subject protections.

•FDA speakers from CBER, CDER, CDRH, CVM, OC, AND ORA
•Featured speakers/panelists from Academia, AAMC, ACRO, ADVAMED, BIO, CDISC, Data Quality Research Institute, MHRA, NIH, AND PhRMA.


1221 22nd Street NW
United States